Articles from the Experts
Our experts offer free thoughts on the market almost every day. Follow the links to the articles on their sites to learn more about how they trade and what brokerage firms they use.
If you want a special on any of the services offered by our experts, visit Trade Comparison's Facebook page and "Like" us to get special discounts from any or all of our experts.
 With Biden heading to the White House, cannabis stocks are picking up a good deal of momentum including Aurora Cannabis (ACB). In addition, Biden’s pick for health and human services secretary, Xavier Becerra, who supports legalization. “Just as we allow alcohol to be sold, we’ve come into the 21st century and announced that it’s better to regulate MJ than criminalize it. The federal government has to catch up and get into the 21st century, first. Secondly, we have to make sure the federal government is helping us, not hindering us, when it comes to coming up with a good way to regulate it,” he once said, as quoted by Marijuana Moment.
In addition, the stock just broke above double top resistance at $11.30. It’s. now moving on to challenge $14.48 potentially. If it can, ACB could see a test of $19.68 last seen in May 2020. The opportunities we find quite often inside Extreme Option Profits.
EARN 58% & MORE Per Trade On Average & Risk 91% LESS Doing It!
Potentially EARN 6,438% More Per Year By Defying All Of the Regular, Ordinary, Common, Boundaries & Restrictions On Trading & Investing (like our model portfolio)…
…With Speed, Convenience, & FREEDOM!…& Risk As Little As $300 & NEVER Own A Single Stock or ETF!
The post Extreme Option Profits Chart of Day…Aurora Cannabis (ACB). appeared first on Trading Concepts, Inc.. |
|
The stock market was weak throughout Friday’s session as Wall Street “sold the new” following details of President-elect Biden’s $1.9 trillion “American Rescue Plan.” Despite control of the executive and legislative branches of government, there is to be some uncertainty over the prospect that the full package will make it through Congress.
The losses capped an overall down week for the major indexes, with the small-caps escaping the damage as traders took profits and of the three-day weekend as the market was closed on Monday.
The Russell 2000 tested a opening low of 2,102 before ending at 2,123 (-1.5%). Near-term and upper support at 2,100-2,080 was challenged but held. A close below the latter would signal a deeper backtest towards 2,070-2,050.
 The Nasdaq settled at 12,998 (-0.9%) following the morning fade to 12,949. Current and upper support at 13,000-12,900 was breached and failed to held. A move below the latter would signal a further retest towards 12,800-12,700.  The S&P 500 finished at 3,768 (-0.7%) with the first half low tapping 3,749. Near-term and upper support at 3,750-3,725 was tripped but held. A close below the latter would suggest additional weakness towards 3,725-3,700.  The Dow closed at 30,814 (-0.6%) after tagging a low of 30,612. New and upper support 30,750-30,500 was breached but held. A move below the latter would indicate further weakness towards 30,250-30,000.  For the week, the Nasdaq and the S&P 500 sank -1.5%. The Dow was down -0.9% while the Russell 2000 gained 1.5%. Let me show you my Step-by-Step Here are a few recent LIVE Trades:
 ANALYST UPGRADES/DOWNGRADESHP Enterprise (HPE) upgraded to Overweight from Neutral at JPMorgan 3D Systems (DDD) downgraded to Underweight from Neutral at JPMorgan   TUESDAY’S EARNINGS ANNOUNCEMENTS After the close: F.N.B. Corporation (FNB), Fulton Financial Corp. (FULT), Interactive Brokers Group Inc. (IBKR), J.B. Hunt Transport Services, Inc. (JBHT), Mission Produce (AVO), Netflix, Inc. (NFLX), Pinnacle Financial Partners, Inc (PNFP), (SmartFinancial, Inc. (SMBK), United Community Banks Inc. (UCBI), Zions Bancorporation (ZION) TUESDAY’S ECONOMIC NEWS   METALS/ OIL   Not sure the best way to get started?Step #1: Get These FREE Reports & Videos |
|
Accolade, a health care technology company that helps employees navigate their medical plans, is buying telemedicine start-up 2nd.MD to bolster its ability to provide users with second opinions, CNBC has learned exclusively. Accolade is close to announcing the acquisition of Houston-based Innovation Specialists, parent company of 2nd.MD, for about $460 million, according to people with knowledge of the situation. The transaction will be half in cash and the rest in Accolade shares, a portion of which is contingent on revenue targets, and will close next month, said the people, who declined to be identified speaking about the deal. The move is said to nearly double Accolade’s addressable market to about $46 billion by giving the company a provider of expert medical opinions from a network of U.S. doctors. Founded in 2011, 2nd.MD automates the process of getting second opinions so they happen within days over video or telephone, rather than taking weeks to schedule as is more typical. “At a critical moment in someone’s health care journey, when you’re making a decision about whether to get a surgery or undertake a particular treatment, often you’re looking for expert guidance,” Accolade CEO Raj Singh said this week in a Zoom interview.
The start-up has 300 corporate customers with more than seven million employees and about $35 million in revenue last year, according to documents viewed by CNBC. Singh said that he plans on incorporating 2nd.MD into his company’s products, as well as offering it on a standalone basis. Just as the digitization of finance has attracted billions of dollars in investment and a flurry of M&A activity, the nascent health tech field has seen a surge in interest during the coronavirus pandemic. Digital health start-ups around the world attracted an estimated $24.1 billion in venture capital funding in 2020, 29% higher than the previous year and hitting a record in the third quarter, according to CB Insights. “How consumers access care and how they want to make decisions about care, all of that is changing, driven by a healthcare system that’s under enormous stress,” Singh said. “You are clearly seeing more opportunities for consolidation in this space.” Accolade, which went public in July, counts CNBC parent Comcast as both a major customer and an investor. Seattle-based Accolade was advised by Goldman Sachs in the deal. I hope this article has been helpful… have a fantastic day!  The post Healthtech firm Accolade is buying telemedicine start-up 2nd.MD for $460 million appeared first on Trading Concepts, Inc.. |
|
The stock market closed mostly lower on Thursday and ahead of President-elect Biden’s announcement after the close on his economic stimulus plans. The major indexes did tap fresh record highs, excluding the S&P 500, with the stimulus package expected to be around $2 trillion. However, the last hour of selling pressure erased much of the gains, excluding the small-caps, as traders also prepared for Friday’s earnings update from the banks ahead of the opening bell.
The Russell 2000 tapped an afternoon all-time high of 2,164 before closing at 2,155 (+2.1%). Unchartered territory and lower resistance at 2,160-2,180 was cleared and held. A close above the latter would indicate additional upside towards 2,200-2,220.
The Nasdaq tested a morning and lifetime peak of 13,220 while finishing at 13,112 (-0.1%). Fresh and lower resistance at 13,200-13,300 was breached but held. A move above the latter would suggest additional strength towards 13,400-13,500.
The Dow settled at 30,991 (-0.2%) after trading to a record high of 31,223. New and lower resistance at 31,200-31,250 was cleared but held. A close above the latter would suggest further upside towards 31,500-31,750.
The S&P 500 traded to an intraday high of 3,823 before ending lower at 3,795 (-0.04%). Key resistance at 3,825 was challenged but held. A close above this level and the recent all-time high of 3,826 would signal additional momentum towards 3,850-3,875.
ANALYST UPGRADES/DOWNGRADESChevron (CVX) upgraded to Outperform from Sector Perform at Scotiabank Delta Air Lines (DAL) downgraded to Neutral from Positive at Susquehanna FRIDAY’S EARNINGS ANNOUNCEMENTS After the close: None FRIDAY’S ECONOMIC NEWS METALS/ OIL Not sure the best way to get started?Step #1: Get These FREE Reports & Videos |
TRADING BLOCK SEGMENT
ODD BLOCK
MAIL BLOCK
AROUND THE BLOCK
|
|
Plug Power (PLUG) is exploding to all-time highs. Over the last few weeks, the stock ran from a low of 15 to $66. And it could run even higher. All as demand for green hydrogen picks up momentum. Better, Goldman Sachs is already calling green hydrogen a “once in a lifetime opportunity,” says Barron’s. The firm also notes the addressable market could be worth up to $11.7 trillion in the next 30 years with the U.S., Asia, and Europe leading the way.
Helping, French automaker Renault just signed a memorandum of understanding to launch a 50-50 venture with Plug Power in France by the end of 2021. They’ll target over 30% share of the fuel-cell powered light commercial vehicle market in Europe, says MarketWatch. The opportunities we find quite often inside Extreme Option Profits.
EARN 58% & MORE Per Trade On Average & Risk 91% LESS Doing It!
Potentially EARN 6,438% More Per Year By Defying All Of the Regular, Ordinary, Common, Boundaries & Restrictions On Trading & Investing (like our model portfolio)…
…With Speed, Convenience, & FREEDOM!…& Risk As Little As $300 & NEVER Own A Single Stock or ETF!
The post Extreme Option Profits Chart of Day…Plug Power (PLUG) appeared first on Trading Concepts, Inc.. |
|
The stock market closed mixed on Wednesday and ahead the House vote to impeach President Trump for the second time. The ongoing political drama comes ahead of President-elect Biden’s administration stimulus proposals and the promise of the vaccine to allow a return to normal activities in the second half of this year.
The Nasdaq traded to an intraday high of 13,171 while closing at 13,128 (+0.4%). Current and lower resistance at 13,100-13,225 was cleared and held. A close above the latter and the all-time high at 13,208 would indicate additional strength towards 13,250-13,375.
The S&P 500 tested a morning peak of 3,820 before finishing at 3,809 (+0.04%). Near-term and lower resistance at 3,825-3,850 was challenged but held. A close above the latter and the recent all-time high of 3,826 would signal additional momentum towards 3,875-3,900.
The Dow ended at 31,060 (-0.03%) despite trading to a high of 31,153. Near-term and lower resistance at 31,100-31,300 was cleared but held. A close above the latter and the recent peak at 31,193 would suggest further upside towards 31,500-31,700.
The Russell 2000 kissed a morning all-time high of 2,130 before closing lower at 2,111 (-0.8%). Fresh and lower resistance at 2,130-2,150 was cleared but held. A close above the latter would indicate additional upside towards 2,160-2,180.
ANALYST UPGRADES/DOWNGRADESExxon Mobil (XOM) upgraded to Overweight from Neutral at JPMorgan Carter's (CRI) downgraded to Equal Weight from Overweight at Wells Fargo THURSDAY’S EARNINGS ANNOUNCEMENTS After the close: Progress Software (PRGS) THURSDAY’S ECONOMIC NEWS METALS/ OIL Not sure the best way to get started?Step #1: Get These FREE Reports & Videos |
|
Shares of General Motors hit a record high Tuesday after the automaker unveiled an electric delivery van and revealed potential plans to delve into futuristic flying cars. The Detroit automaker’s stock closed up 6.2% at $47.82 a share, setting a new closing record after hitting an intraday high of $48.95 earlier Tuesday morning. Both the closing and intraday prices were all-time records since the automaker emerged from bankruptcy at the tail end of the Great Recession and started publicly trading again in 2010. The previous highs occurred in October 2017. GM CEO Mary Barra and other executives discussed the plans as part of the CES technology conference, which is being streamed online this year. The EV600 electric van is scheduled to go on sale later this year through a new commercial business unit of GM’s called BrightDrop. The division is planning a full portfolio of electric products, not just vehicles, including a delivery pallet that was unveiled Tuesday. Morgan Stanley analyst Adam Jonas in a note to investors Tuesday said BrightDrop “represents yet another decisive action in an evolving series of forthcoming actions that position the company to leverage its strengths.”
Michael Simcoe, vice president of GM global design, said each concept reflected “the needs and wants of the passengers at a particular moment in time and GM’s vision of the future of transportation.” “This is a special moment for General Motors as we reimagine the future of personal transportation for the next five years and beyond,” Simcoe said. The flying vehicle is designed to hold one passenger and travel roughly 56 mph between rooftops and other urban destinations, according to the company. A GM spokeswoman confirmed GM has designed models of both autonomous concepts, but computer renderings were simulated during the presentation. She declined to provide other details. Despite uncertainties around personal air mobility, Morgan Stanley expects the autonomous urban aircraft market may be worth $1.5 trillion by 2040. The segment is attracting major investments from the automotive and aviation industries. Fiat Chrysler earlier Tuesday announced a new partnership with air mobility company Archer to help lower costs and accelerate the launch of an eVTOL aircraft. Other companies involved in the segment include Joby, Boeing-backed Wisk and Hyundai Motor. Have a wonderful day and hope to hear from you soon.  The post GM shares hit record high as automaker reveals electric van and delves into flying cars appeared first on Trading Concepts, Inc.. |
|
The stock market traded on both sides of the ledger before closing higher on Tuesday and ahead of a congressional vote on a resolution that calls for Vice President Pence to invoke the 25th amendment and removing President Trump from office.
The vaccine continues to be rolled out in the U.S. amid ongoing and rising coronavirus cases but the pace in some cities has been slower than anticipated and continues to weigh on sentiment.
The Russell 2000 tapped an afternoon all-time high of 2,128 before closing at 2,127 (+1.8%). Unchartered territory and lower resistance at 2,120-2,140 was cleared and held. A close above the latter would indicate additional upside towards 2,160-2,180.
The Nasdaq tested a late day peak of 13,105 while finishing at 13,073 (+0.3%). Current and lower resistance at 13,100-13,225 was breached but held. A move above the latter and the lifetime high at 13,208 would suggest additional strength towards 13,250-13,375.
The Dow settled at 31,068 (+0.2%) while trading to a record high of 31,114. Near-term and lower resistance at 31,100-31,300 was cleared but held. A close above the latter and the recent peak at 31,193 would suggest further upside towards 31,500-31,700.
The S&P 500 traded to an intraday high of 3,810 before ending at 3,801 (+0.04%). Near-term and lower resistance at 3,800-3,825 was recovered. A close above the latter and the recent all-time high of 3,826 would signal additional momentum towards 3,850-3,875.
ANALYST UPGRADES/DOWNGRADESAflac (AFL) upgraded to Overweight from Equal Weight at Morgan Stanley Commercial Metals (CMC) downgraded to Underperform from Neutral at BofA WEDNESDAY’S EARNINGS ANNOUNCEMENTS After the close: Volt Information Sciences (VOLT), Washington Federal (WAFD) WEDNESDAY’S ECONOMIC NEWS METALS/ OIL Not sure the best way to get started?Step #1: Get These FREE Reports & Videos |
|
Gene-editing has become one of the top investing buzzwords. All as gene editing show progress in identifying and potentially curing diseases. Plus, according to Ark Investment Management CEO Cathie Wood said, “I would have to say the biggest upside surprises are going to come from the genomic space. That’s because the convergence of DNA editing, artificial intelligence, and gene therapies, importantly CRISPR gene editing, is going to cure disease,” as quoted by The Motley Fool. Even more impressive, according to Interesting Engineering, “researchers have already identified DNA errors as the cause of nearly 7,000 diseases. Thankfully, the growing world of genome editing could be the ‘spell-checker’ needed to detect and eventually fix these.” In short, everyone should be excited about the potential here.
Global X Genomics and Biotechnology ETF (GNOM) One of the best ways to diversify your gene editing portfolio is with an ETF such as the Global X Genomics and Biotechnology ETF. According to Global X, it “seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology.”
The opportunities we find quite often inside Extreme Option Profits.
EARN 58% & MORE Per Trade On Average & Risk 91% LESS Doing It!
Potentially EARN 6,438% More Per Year By Defying All Of the Regular, Ordinary, Common, Boundaries & Restrictions On Trading & Investing (like our model portfolio)…
…With Speed, Convenience, & FREEDOM!…& Risk As Little As $300 & NEVER Own A Single Stock or ETF!
The post Extreme Option Profits Chart of Day…Global X Genomics and Biotechnology ETF (GNOM) appeared first on Trading Concepts, Inc.. |
